Unknown PHASE3 INTERVENTIONAL NCT00000132

Early Manifest Glaucoma Trial (EMGT)

Sponsor: National Eye Institute (NEI)

Interventions Argon Laser Trabeculoplasty Betaxolol

Updated 5 times since 2017 Last updated: Jun 23, 2005 Started: Oct 31, 1992

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE3 trial investigates Open-Angle Glaucoma and is currently ongoing. National Eye Institute (NEI) leads this study, which shows 5 recorded versions since 1992 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE3
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE3

Status: Unknown Status → Unknown
Jan 2021 — Jul 2024 [monthly]

Unknown Status PHASE3
Jun 2018 — Jan 2021 [monthly]

Unknown Status PHASE3
Jan 2017 — Jun 2018 [monthly]

Unknown Status PHASE3

First recorded

Oct 1992

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Eye Institute (NEI)

Data source: National Eye Institute (NEI)

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Helsingborg, Sweden
• Malmo, Sweden